Teyi Pharmaceutical Group Co.,Ltd (SHE:002728)

SHE:002728 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022	Dec 31, 2020
Operating Revenue	817.43	686.91	1,066	886.15	757.93	632.22
Other Revenue	0.88	0.88	0.74	0.43	0.23	0.48
Revenue	818.31	687.79	1,067	886.57	758.16	632.7
Revenue Growth (YoY)	-11.79%	-35.55%	20.38%	16.94%	19.83%	-31.31%
Cost of Revenue	398.87	386.47	467.98	451.83	356.12	330.93
Gross Profit	419.43	301.32	599.23	434.74	402.04	301.76
Selling, General & Admin	311.28	225.54	240.67	176.38	175.95	153.87
Research & Development	41.75	43.33	43.06	38.01	37.78	36.5
Other Operating Expenses	4.94	2.05	9.38	1.75	9.27	8.19
Operating Expenses	358.29	270.89	293.19	216.74	224.72	197.63
Operating Income	61.15	30.43	306.04	217.99	177.33	104.13
Interest Expense	-5.78	-5.32	-16.36	-29.13	-29.51	-42.72
Interest & Investment Income	8.88	10.34	12.34	8.55	12.14	16.96
Other Non Operating Income (Expenses)	-0.52	-0.45	-0.4	-1.44	-0.42	-0.6
EBT Excluding Unusual Items	63.72	34.99	301.61	195.97	159.53	77.77
Impairment of Goodwill	-11.63	-11.63	-13.17	-	-23.06	-22.42
Gain (Loss) on Sale of Assets	-0.05	0.01	0.12	0.04	0.1	-0.29
Asset Writedown	-0.16	-0.16	-0.27	-0.12	-0.37	-0.02
Other Unusual Items	-1.61	-1.16	4.7	0.43	10.91	-1.75
Pretax Income	50.28	22.05	292.99	196.32	147.1	53.28
Income Tax Expense	7.37	1.56	39.82	18.12	20.18	9.46
Net Income	42.91	20.5	253.18	178.2	126.92	43.82
Net Income to Common	42.91	20.5	253.18	178.2	126.92	43.82
Net Income Growth	-72.65%	-91.91%	42.07%	40.41%	189.66%	-74.48%
Shares Outstanding (Basic)	529	512	460	438	401	391
Shares Outstanding (Diluted)	529	512	460	438	401	391
Shares Change (YoY)	14.39%	11.31%	5.16%	9.09%	2.75%	-2.52%
EPS (Basic)	0.08	0.04	0.55	0.41	0.32	0.11
EPS (Diluted)	0.08	0.04	0.55	0.41	0.32	0.11
EPS Growth	-76.09%	-92.73%	35.10%	28.71%	181.91%	-73.82%
Free Cash Flow	-2.85	-136.11	112.51	281.39	147.24	79.57
Free Cash Flow Per Share	-0.01	-0.27	0.24	0.64	0.37	0.20
Dividend Per Share	0.050	0.050	0.357	0.332	0.332	0.332
Dividend Growth	-86.00%	-86.00%	7.69%	-	-	-13.35%
Gross Margin	51.26%	43.81%	56.15%	49.04%	53.03%	47.69%
Operating Margin	7.47%	4.42%	28.68%	24.59%	23.39%	16.46%
Profit Margin	5.24%	2.98%	23.72%	20.10%	16.74%	6.93%
Free Cash Flow Margin	-0.35%	-19.79%	10.54%	31.74%	19.42%	12.58%
EBITDA	126.57	94.79	366.14	270.52	228.63	155.16
EBITDA Margin	15.47%	13.78%	34.31%	30.51%	30.16%	24.52%
D&A For EBITDA	65.42	64.36	60.1	52.52	51.31	51.03
EBIT	61.15	30.43	306.04	217.99	177.33	104.13
EBIT Margin	7.47%	4.42%	28.68%	24.59%	23.39%	16.46%
Effective Tax Rate	14.66%	7.06%	13.59%	9.23%	13.72%	17.76%
Revenue as Reported	818.31	687.79	1,067	886.57	758.16	632.7

Source: S&P Global Market Intelligence. Standard template. Financial Sources.